journal
https://read.qxmd.com/read/38346711/small-non-coding-rnas-in-male-reproduction
#21
JOURNAL ARTICLE
Opeyemi Olotu, Ammar Ahmedani, Noora Kotaja
Male reproductive functions are strictly regulated in order to maintain sperm production and fertility. All processes are controlled by precise regulation of gene expression, which creates specific gene expression programs for different developmental stages and cell types, and forms the functional basis for the reproductive system. Small non-coding RNAs (sncRNAs) are involved in gene regulation by targeting mRNAs for translational repression and degradation through complementary base pairing to recognize their targets...
November 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/37913788/obesity-and-in-vitro-fertilization
#22
JOURNAL ARTICLE
Emily L Ferrell, Abira A Choudhry, Samantha B Schon
Obesity is a highly prevalent chronic disease with a significant effect on reproductive-age women. The clinical implications of obesity on fertility and pregnancy are well studied citing ovulatory dysfunction, hormonal imbalances, higher miscarriage rates, and increased maternal and neonatal risks. For this reason, many patients with obesity seek reproductive specialists to help build their families. Despite this literature base, the effect of weight loss interventions prior to assisted reproductive technology (ART) is lacking...
November 1, 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/37913787/the-role-of-the-primary-care-physician-in-the-assessment-and-management-of-polycystic-ovary-syndrome
#23
JOURNAL ARTICLE
Carolyn Ee
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous female endocrine disorder with manifestations that span the hormonal, reproductive, metabolic, and psychological. Primary care physicians (PCPs), also known as family physicians or general practitioners, play a key role in the diagnosis, assessment, and management of PCOS. This article outlines the role of the PCP in the timely and accurate diagnosis, provision of information and education, lifestyle and weight management, and management of key features such as hyperandrogenism, irregular cycles, infertility, emotional well-being, and cardiometabolic risk...
November 1, 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38320577/the-upper-reproductive-system-microbiome-evidence-beyond-the-uterus
#24
REVIEW
Analuce Canha-Gouveia, Valentina Di Nisio, Andres Salumets, Pauliina Damdimopoulou, Pilar Coy, Signe Altmäe, Alberto Sola-Leyva
The microbiome of the female upper reproductive system has garnered increasing recognition and has become an area of interest in the study of women's health. This intricate ecosystem encompasses a diverse consortium of microorganisms (i.e., microbiota) and their genomes (i.e., microbiome) residing in the female upper reproductive system, including the uterus, the fallopian tubes, and ovaries. In recent years, remarkable advancements have been witnessed in sequencing technologies and microbiome research, indicating the potential importance of the microbial composition within these anatomical sites and its impact in women's reproductive health and overall well-being...
September 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38320576/exploring-the-microbiome-in-human-reproductive-tract-high-throughput-methods-for-the-taxonomic-characterization-of-microorganisms
#25
JOURNAL ARTICLE
Eduardo Salas-Espejo, Laura C Terrón-Camero, José L Ruiz, Nerea M Molina, Eduardo Andrés-León
Microorganisms are important due to their widespread presence and multifaceted roles across various domains of life, ecology, and industries. In humans, they underlie the proper functioning of multiple systems crucial to well-being, including immunological and metabolic functions. Emerging research addressing the presence and roles of microorganisms within human reproduction is increasingly relevant. Studies implementing new methodologies (e.g., to investigate vaginal, uterine, and semen microenvironments) can now provide relevant insights into fertility, reproductive health, or pregnancy outcomes...
September 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38320575/microbiome-in-reproduction-analysis-methods-novel-techniques-and-state-of-the-art-in-female-reproductive-health
#26
JOURNAL ARTICLE
Signe Altmäe
No abstract text is available yet for this article.
September 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38320574/microbiome-in-reproduction
#27
JOURNAL ARTICLE
Kathleen Hoeger, Terhi Piltonen
No abstract text is available yet for this article.
September 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38065552/uterine-microbiome-does-the-sampling-technique-matter
#28
JOURNAL ARTICLE
Kreete Lüll, Elin Org
Studies have proven the significance of microbial communities in various parts of the human body for health. In recent years it has been discovered that the uterine cavity is not sterile, and endometrium has its own microbiome which appears to have an impact on female fertility and gynecological pathologies. Lactobacillus has shown to dominate the microbial profile in the uterus and is considered an indicator of a healthy uterine environment. Yet, many argue that the Lactobacillus dominance is due to vaginal contamination during the sampling process...
September 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38198791/obesity-and-male-infertility-true-true-and-unrelated
#29
REVIEW
Carl Ceraolo, Amanda Rubano, J Scott Gabrielsen
While the prevalence of obesity has rapidly increased worldwide, there has also been a notable decline in semen parameters over the last several decades. While obesity can negatively impact reproductive hormones, many studies have sought a link between rising obesity and decreased male fertility potential. Nonetheless, few data support a direct link between the two. The focus on obesity as a causative factor in male infertility can potentially result in patient harm through delayed fertility treatment and missed diagnoses...
July 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38198790/obesity-and-reproduction
#30
JOURNAL ARTICLE
Wendy S Vitek
No abstract text is available yet for this article.
July 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38198789/introduction-of-the-guest-editor-for-obesity-in-reproduction
#31
JOURNAL ARTICLE
Kathleen M Hoeger, Terhi Piltonen
No abstract text is available yet for this article.
July 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38242538/introduction-to-seminars-in-reproductive-medicine-new-editors-in-chief
#32
JOURNAL ARTICLE
Kathleen M Hoeger, Terhi T Piltonen
No abstract text is available yet for this article.
March 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38113883/beyond-counting-sheep-exploring-the-link-between-polycystic-ovary-syndrome-and-sleep-health
#33
JOURNAL ARTICLE
Nur K Abdul Jafar, Christie J Bennett, Lisa J Moran, Darren R Mansfield
Polycystic ovary syndrome (PCOS) is a common hormonal condition with reproductive, metabolic, and psychological sequelae that affects 8 to 13% of reproductive-aged women and 3 to 11% of adolescent girls. Sleep is often compromised in women with PCOS due to increased rates of sleep problems, with the most established problem being obstructive sleep apnea (OSA). OSA is highly prevalent in reproductive-aged adult women with PCOS, but not so in adolescence. The international evidence-based PCOS guideline to improve health outcomes in women with PCOS indicated routine screening to identify and alleviate symptoms of OSA...
March 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38113882/considerations-in-the-treatment-of-depression-and-anxiety-in-women-with-pcos
#34
JOURNAL ARTICLE
Snigdha Alur-Gupta, Anuja Dokras
Women with polycystic ovary syndrome (PCOS) are known to be at a greater risk of depression and anxiety. What is less clear is whether existing treatments for PCOS are effective in managing this increased risk and what the optimal approach to treatment is. In this review, currently available interventions are explored including lifestyle modifications, oral contraceptives, insulin sensitizing agents, psychosocial interventions and psychiatric medications. While data are often conflicting, lifestyle interventions, and cognitive behavioral therapy (CBT) appear most promising in reducing depression and anxiety symptoms in this population...
March 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38113881/broadening-the-scope-of-polycystic-ovary-syndrome-pcos-care-insights-from-the-2023-international-evidence-based-pcos-guideline
#35
JOURNAL ARTICLE
Chau Thien Tay, Mahnaz Bahri Khomami
No abstract text is available yet for this article.
March 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/38113880/introduction-to-seminars-in-reproductive-medicine-new-editors-in-chief
#36
JOURNAL ARTICLE
Kathleen M Hoeger, Terhi T Piltonen
No abstract text is available yet for this article.
March 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/36626916/improving-access-to-and-quality-of-postpartum-contraception-provision
#37
JOURNAL ARTICLE
Michelle Cooper, Sharon Cameron
Sexual activity and fertility can resume shortly after childbirth, but there are barriers to contraceptive access in the postpartum period. Unintended pregnancy and short interpregnancy intervals (of less than one year) can increase the risk of obstetric and neonatal complications. The antenatal period presents an opportunity to discuss contraceptive options, many of which can be safely initiated immediately after childbirth. Successful delivery of a postpartum contraception program requires an adequate number of maternity staff trained to provide the full range of methods...
January 10, 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/36626915/medical-abortion-before-confirmed-intrauterine-pregnancy-a-systematic-review
#38
JOURNAL ARTICLE
Karin Brandell, John J Reynolds-Wright, Clare Boerma, Gillian Gibson, Helena Hognert, Heera Tuladhar, Oskari Heikinheimo, Sharon Cameron, Kristina Gemzell-Danielsson
"Very early medical abortion" (VEMA) refers to medical abortion (with mifepristone and misoprostol) before intrauterine pregnancy is visualized on ultrasound. Our aim is to present the current evidence on efficacy, safety (focused on ectopic pregnancies), and how to assess treatment success of VEMA. We conducted a systematic review of studies reporting outcomes of VEMA. The field is small and so our objective was to map all relevant literature, without conducting meta-analysis. We searched PubMed, Medline, and Embase on April 19, 2022...
January 10, 2023: Seminars in Reproductive Medicine
https://read.qxmd.com/read/36535662/the-intersection-of-abortion-and-criminalization-abortion-access-for-people-in-prisons
#39
JOURNAL ARTICLE
Martha J Paynter, Wendy V Norman
Most incarcerated women are of reproductive age, and more than a third of women will have an abortion during their reproductive years. Although women are the fastest growing population in Canadian prisons, no one has studied the effect of their incarceration on access to abortion services. Studies outside of Canada indicate rates of abortion are higher among people experiencing incarceration than in the general population, and that abortion access is often problematic. Although international standards for abortion care among incarcerated populations exist, there conversely appear to be no Canadian guidelines or procedures to facilitate unintended pregnancy prevention or management...
December 19, 2022: Seminars in Reproductive Medicine
https://read.qxmd.com/read/36478566/opportunities-for-increasing-access-to-effective-contraception-in-australia
#40
JOURNAL ARTICLE
Danielle Mazza, Jessica R Botfield
Effective contraception can prevent unintended pregnancies, however there is an unmet need for effective contraception in Australia. Despite their being a range of contraceptive methods available, access to these remains equitable and uptake of the most effective methods is low. There is an opportunity to reduce the rate of unintended pregnancies in Australia by improving the uptake of effective contraception for those who desire this. Improving access will require increasing consumer health literacy about contraception, as well as the option of telehealth as a mode of service delivery, and stronger investment in contraceptive services through appropriate reimbursement for providers...
December 7, 2022: Seminars in Reproductive Medicine
journal
journal
34875
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.